Carelizumab Combined With Regorafenib in the Treatment of HCC（CARE-2020）
Clinical trial NCT04806243 · UNKNOWN
Trial details
- NCT number
- NCT04806243
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2022-01-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.